TIBER CREEK GROUP for PHRMA
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Issues related to international trade.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
Health Issues HCR
Issues related to pharmaceutical drug pricing, S. 469/H.R. 1245 Affordable and Safe Prescription Drug Importation Act. Issues related to pharmaceutical drug pricing and transparency. S. 3239 - RACE for Children Act, S. 1348 - SPIKE Act of 2017. S. 637 - C-THRU Act of 2017. S. 934 - FDARA, H.R. 2430 - FDARA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| ANDREW MCKECHNIE | — |
| JENNIFER OLSON | — |
Medicare/Medicaid MMM
IPAB, S. 251 Protecting Medicare from Executive Action Act of 2017, H.R. 849 Protecting Seniors' Access to Medicare Act of 2017, issues related to drug pricing. S.260 - Protecting Seniors Access to Medicare Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| ANDREW MCKECHNIE | — |
| JENNIFER OLSON | — |
Budget/Appropriations BUD
S.Amdt.134 to S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026, H.Res.48 Budget Reconciliation Resolution, issues related to amendments on drug pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| ANDREW MCKECHNIE | — |
| JENNIFER OLSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.